These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

407 related items for PubMed ID: 1860008

  • 1. Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria.
    Mathiesen ER, Hommel E, Giese J, Parving HH.
    BMJ; 1991 Jul 13; 303(6794):81-7. PubMed ID: 1860008
    [Abstract] [Full Text] [Related]

  • 2. Effect of deletion polymorphism of angiotensin converting enzyme gene on progression of diabetic nephropathy during inhibition of angiotensin converting enzyme: observational follow up study.
    Parving HH, Jacobsen P, Tarnow L, Rossing P, Lecerf L, Poirier O, Cambien F.
    BMJ; 1996 Sep 07; 313(7057):591-4. PubMed ID: 8806248
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effect of captopril on blood pressure and kidney function in normotensive insulin dependent diabetics with nephropathy.
    Parving HH, Hommel E, Damkjaer Nielsen M, Giese J.
    BMJ; 1989 Aug 26; 299(6698):533-6. PubMed ID: 2507061
    [Abstract] [Full Text] [Related]

  • 5. Protection of kidney function and decrease in albuminuria by captopril in insulin dependent diabetics with nephropathy.
    Parving HH, Hommel E, Smidt UM.
    BMJ; 1988 Oct 29; 297(6656):1086-91. PubMed ID: 3143437
    [Abstract] [Full Text] [Related]

  • 6. Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. European Microalbuminuria Captopril Study Group.
    Viberti G, Mogensen CE, Groop LC, Pauls JF.
    JAMA; 1994 Jan 26; 271(4):275-9. PubMed ID: 8295285
    [Abstract] [Full Text] [Related]

  • 7. Long-term beneficial effect of ACE inhibition on diabetic nephropathy in normotensive type 1 diabetic patients.
    Parving HH, Hommel E, Jensen BR, Hansen HP.
    Kidney Int; 2001 Jul 26; 60(1):228-34. PubMed ID: 11422755
    [Abstract] [Full Text] [Related]

  • 8. Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria.
    Marre M, Chatellier G, Leblanc H, Guyene TT, Menard J, Passa P.
    BMJ; 1988 Oct 29; 297(6656):1092-5. PubMed ID: 2848604
    [Abstract] [Full Text] [Related]

  • 9. Captopril reduces the risk of nephropathy in IDDM patients with microalbuminuria. The Microalbuminuria Captopril Study Group.
    Diabetologia; 1996 May 29; 39(5):587-93. PubMed ID: 8739919
    [Abstract] [Full Text] [Related]

  • 10. Albuminuria induced by exercise in hypertensive type I and type II diabetic patients: a randomised, double-blind study on the effects of acute administration of captopril and nifedipine.
    Romanelli G, Giustina A, Cravarezza P, Caldonazzo A, Agabiti-Rosei E, Giustina G.
    J Hum Hypertens; 1991 Jun 29; 5(3):167-73. PubMed ID: 1920340
    [Abstract] [Full Text] [Related]

  • 11. Reduction in albuminuria predicts a beneficial effect on diminishing the progression of human diabetic nephropathy during antihypertensive treatment.
    Rossing P, Hommel E, Smidt UM, Parving HH.
    Diabetologia; 1994 May 29; 37(5):511-6. PubMed ID: 8056190
    [Abstract] [Full Text] [Related]

  • 12. Captopril acutely lowers albuminuria in normotensive patients with diabetic nephropathy.
    Elving LD, Wetzels JF, de Nobel E, Hoitsma AJ, Berden JH.
    Am J Kidney Dis; 1992 Dec 29; 20(6):559-63. PubMed ID: 1462982
    [Abstract] [Full Text] [Related]

  • 13. Low-dose angiotensin converting enzyme inhibitors: effect on renal function in normo- and hypertensive type 1 diabetic patients.
    Ciavarella A, Mustacchio A, Silletti A, Franchi R, Levorato M, Campieri C, Borgnino LC, Capozzi G, Morotti L, Vannini P.
    Eur J Med; 1992 Sep 29; 1(5):268-72. PubMed ID: 1341608
    [Abstract] [Full Text] [Related]

  • 14. [The effect of captopril therapy on the degree of microalbuminuria in diabetic children and adolescents with incipient nephropathy].
    Barkai L, Soós A, Vámosi I.
    Orv Hetil; 1996 Nov 17; 137(46):2565-8. PubMed ID: 9005384
    [Abstract] [Full Text] [Related]

  • 15. Angiotensin converting enzyme inhibitor therapy to decrease microalbuminuria in normotensive children with insulin-dependent diabetes mellitus.
    Cook J, Daneman D, Spino M, Sochett E, Perlman K, Balfe JW.
    J Pediatr; 1990 Jul 17; 117(1 Pt 1):39-45. PubMed ID: 2196359
    [Abstract] [Full Text] [Related]

  • 16. The effects of angiotensin-converting enzyme inhibitors on the clinical and biochemical parameters in diabetic nephropathy.
    Gültekin F, Erdoğan GH, Ozersoy U, Alagözlü H.
    Ren Fail; 1993 Jul 17; 15(5):615-22. PubMed ID: 8290708
    [Abstract] [Full Text] [Related]

  • 17. Comparison of reduction in microalbuminuria by enalapril and hydrochlorothiazide in normotensive patients with insulin dependent diabetes.
    Hallab M, Gallois Y, Chatellier G, Rohmer V, Fressinaud P, Marre M.
    BMJ; 1993 Jan 16; 306(6871):175-82. PubMed ID: 8443481
    [Abstract] [Full Text] [Related]

  • 18. Comparison between perindopril and nifedipine in hypertensive and normotensive diabetic patients with microalbuminuria. Melbourne Diabetic Nephropathy Study Group.
    BMJ; 1991 Jan 26; 302(6770):210-6. PubMed ID: 1998761
    [Abstract] [Full Text] [Related]

  • 19. Short-term administration of captopril and nifedipine and exercise-induced albuminuria in normotensive diabetic patients with early-stage nephropathy.
    Romanelli G, Giustina A, Bossoni S, Caldonazzo A, Cimino A, Cravarezza P, Giustina G.
    Diabetes; 1990 Nov 26; 39(11):1333-8. PubMed ID: 2227107
    [Abstract] [Full Text] [Related]

  • 20. Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. A 7-year follow-up study.
    Ravid M, Lang R, Rachmani R, Lishner M.
    Arch Intern Med; 1996 Feb 12; 156(3):286-9. PubMed ID: 8572838
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.